General Information of Drug (ID: DMFG7CC)

Drug Name
OTB-658 Drug Info
Indication
Disease Entry ICD 11 Status REF
Tuberculosis 1B10-1B14 Preclinical [1]
Cross-matching ID
TTD Drug ID
DMFG7CC

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
TP-434 DM5A31S Intra-abdominal infection 1A40 Approved [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bacterial Ribosome (Bact RIBS) TTND3XS NOUNIPROTAC Inhibitor [2]

References

1 In Vitro and In Vivo Activity of Oxazolidinone Candidate OTB-658 against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0097421.
2 Clinical pipeline report, company report or official report of TB
3 Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic. Antimicrob Agents Chemother. 2012 May;56(5):2559-64.